Decan, Decan, Decan,A typical down ramp post from you. Full...

Decan, Decan, Decan,

A typical down ramp post from you. Full marks for consistency.

You have total misinterpreted the release, to think that they are going to only have $3M in sales.

What they said was that they are on-track to reach the $3M in sales for TruScreen.

If you have a look at past ASX releases (e.g. 25th Nov - Corp. Briefing AGM 2008, see P15) they have a 'Sales Projections' chart that has appeared in various releases and analyst reports. It forecasts:
- $3M for Truscreen in in 2009, $52M in 2010 and $121 in 2011.
- 2009 also has $0.8M for Mediscan and $3M for CerviScreen

There's no reason they shouldn't meet their budget for Mediscan, and according to yesterday's release regarding CerviScreen "To date, 150,000 units have been manufactured and are ready for distribution". They note that "Sales under those agreements will not materialise before the registration of the CerviScreen product with relevant drugs administration authorities."

If that last sentence is what you're basing a claimed "downgrade" on, then you're drawing a VERY long bow. They've got sales and product ready to go, just awaiting government approval for their distributor to be able to sell it. There's every chance that it will happen prior to 30th June, but if not, then really ... big deal ... it's going to happen.

Either you're not well enough researched, or desperate in finding new ways to try to downramp Polartechnics. Doing so on the FER forum is sinking to a new low.

At least Polartechnics actually have revenue, and the company has its greatest value in continued operations ... in comparison to your beloved GBI, that is still waiting to commercialise and all of your value calculations are based on the company being sold.

Cheers.